Atlas Trials

Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch

Clinical trial NCT01191359 · COMPLETED

Trial details

NCT number
NCT01191359
Sponsor
ALK-Abelló A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergy
Start date
2010-01-01
Primary completion
2011-01-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.